501 - 525 of 7939 Results
Title
Year
-
OPENTitle: GABAA Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 13Issue #: 12Start Page: 1711End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci13121711Best OA location URL: https://www.mdpi.com/2076-3425/13/12/1711/pdf?version=1702360159Citation Count: 1
-
OPENTitle: Molecular Mechanisms of Cationic Fusogenic Liposome Interactions with Bacterial EnvelopesJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 145Issue #: 51Start Page: 28240End Page: 28250Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/jacs.3c11463Best OA location URL: https://doi.org/10.1021/jacs.3c11463Citation Count: 7
- Alpha-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinsons disease2023OPENTitle: Alpha-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinsons diseaseJournal Name:Publisher: Cold Spring Harbor LaboratoryVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/2023.12.11.571045Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2023/12/11/2023.12.11.571045.full.pdfCitation Count: 0
- Evaluating the ability of a predictive vision-based machine learning model to measure changes in gait in response to medication and DBS within individuals with Parkinson’s disease2023OPENTitle: Evaluating the ability of a predictive vision-based machine learning model to measure changes in gait in response to medication and DBS within individuals with Parkinson’s diseaseJournal Name: BioMedical Engineering OnLinePublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12938-023-01175-yBest OA location URL: https://biomedical-engineering-online.biomedcentral.com/counter/pdf/10.1186/s12938-023-01175-yCitation Count: 2
-
RESTRICTEDTitle: Microbial amyloids in neurodegenerative amyloid diseasesJournal Name: The FEBS JournalPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/febs.17023Citation Count: 0
- Toward Omics-Scale Quantitative Mass Spectrometry Imaging of Lipids in Brain Tissue Using a Multiclass Internal Standard Mixture2023OPENTitle: Toward Omics-Scale Quantitative Mass Spectrometry Imaging of Lipids in Brain Tissue Using a Multiclass Internal Standard MixtureJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 95Issue #: 51Start Page: 18719End Page: 18730Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.analchem.3c02724Citation Count: 9
- Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications2023OPENTitle: Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial ImplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 3Start Page: 312End Page: 314Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13890Citation Count: 1
- Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson Disease2023OPENTitle: Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/nxg.0000000000200115Citation Count: 0
-
OPENTitle: Prevalence and Incidence of Parkinson's Disease in Latin America: A Meta‐AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 1Start Page: 105End Page: 118Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29682Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29682Citation Count: 2
- Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and Dementia with Lewy bodies2023OPENTitle: Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and Dementia with Lewy bodiesJournal Name:Publisher: Cold Spring Harbor LaboratoryVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/2023.12.07.570569Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2023/12/08/2023.12.07.570569.full.pdfCitation Count: 0
- Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases2023OPENTitle: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseasesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00604-yBest OA location URL: https://www.nature.com/articles/s41531-023-00604-y.pdfCitation Count: 10
- Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology2023OPENTitle: Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathologyJournal Name:Publisher: Cold Spring Harbor LaboratoryVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/2023.12.05.569878Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2023/12/07/2023.12.05.569878.full.pdfCitation Count: 0
-
OPENTitle: From policy to practice: Lessons learned from an open science funding initiativeJournal Name: PLOS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 12Start Page: e1011626End Page: e1011626Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1011626Best OA location URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1011626&type=printableCitation Count: 1
-
OPENTitle: Gut mucosal cells transfer α-synuclein to the vagus nerveJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 8Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.172192Best OA location URL: https://doi.org/10.1172/jci.insight.172192Citation Count: 13
-
OPENTitle: Multimodal assessment of mitochondrial function in Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 1Start Page: 267End Page: 280Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad364Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad364/54040745/awad364.pdfCitation Count: 8
- Altered dynamic functional network connectivity in drug-naïve Parkinson’s disease patients with excessive daytime sleepiness2023OPENTitle: Altered dynamic functional network connectivity in drug-naïve Parkinson’s disease patients with excessive daytime sleepinessJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2023.1282962Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2023.1282962/pdf?isPublishedV2=FalseCitation Count: 0
-
OPENTitle: Organ aging signatures in the plasma proteome track health and diseaseJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 624Issue #: 7990Start Page: 164End Page: 172Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41586-023-06802-1Best OA location URL: https://www.nature.com/articles/s41586-023-06802-1.pdfCitation Count: 95
-
OPENTitle: Population fraction of Parkinson’s disease attributable to preventable risk factorsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00603-zBest OA location URL: https://www.nature.com/articles/s41531-023-00603-z.pdfCitation Count: 4
-
OPENTitle: Basal activity of PINK1 and PRKN in cell models and rodent brainJournal Name: AutophagyPublisher: Informa UK LimitedVol: 20Issue #: 5Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2023.2286414Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2023.2286414?needAccess=trueCitation Count: 8
-
OPENTitle: A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 12Start Page: 113544End Page: 113544Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2023.113544Best OA location URL: http://www.cell.com/article/S2211124723015565/pdfCitation Count: 4
-
OPENTitle: Cell-free RNA signatures predict Alzheimer’s diseaseJournal Name: iSciencePublisher: Elsevier BVVol: 26Issue #: 12Start Page: 108534End Page: 108534Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2023.108534Best OA location URL: http://www.cell.com/article/S2589004223026111/pdfCitation Count: 2
- Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)2023OPENTitle: Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)Journal Name: IBRO Neuroscience ReportsPublisher: Elsevier BVVol: 15Issue #:Start Page: 320End Page: 326Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ibneur.2023.10.001Best OA location URL: http://www.ibroneuroreports.org/article/S2667242123022716/pdfCitation Count: 0
-
RESTRICTEDTitle: Cytokine activity in Parkinson's diseaseJournal Name: Neuronal SignalingPublisher: Portland Press Ltd.Vol: 7Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/ns20220063Best OA location URL: https://portlandpress.com/neuronalsignal/article-pdf/doi/10.1042/NS20220063/951916/ns-2022-0063c.pdfCitation Count: 0
- In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids2023OPENTitle: In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloidsJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 12Start Page: 2034End Page: 2047Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41592-023-02080-xBest OA location URL: https://www.nature.com/articles/s41592-023-02080-x.pdfCitation Count: 12
- Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures2023OPENTitle: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structuresJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 48Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adk6191Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adk6191?download=trueCitation Count: 11